Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M 2 ES)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M 2 ES)

Published:2018-12-10 Issue: Volume: Page:e22257
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Guo Lifang¹²^ORCID,Geng Xingchao³,Liu Li³,Miao Yufa³,Lin Zhi³,Yu Min³,Fu Yan²,Liu Lihong¹,Li Bo³,Luo Yongzhang²

Affiliation:

1. Pharmacy Department of Beijing Chao‐Yang HospitalCapital Medical UniversityBeijing China

2. National Engineering Laboratory for Anti‐Tumor Protein Therapeutics, School of Life Sciences, Tsinghua UniversityBeijing China

3. National Center for Safety Evaluation of Drugs, National Institute for Food and Drug ControlBeijing China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22257

Reference30 articles.

1. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

2. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth

3. Possible role of endostatin in the antiangiogenic therapy of diabetic retinopathy

4. Endostatin sensitizes p53-deficient non-small-cell lung cancer to genotoxic chemotherapy by targeting DNA-dependent protein kinase catalytic subunit

5. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals;Journal of Separation Science;2020-03-11

2. Biophysical and biological characterization of PEGylated recombinant human endostatin;Clinical and Experimental Pharmacology and Physiology;2019-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3